Lexotan |
Bromazepam |
Ro-53350 |
Lectopam |
Ultramidol |
Teva-bromazepam |
Riva-bromazepam 6 mg |
Riva-bromazepam 3 mg |
Penta-bromazepam Tablets |
Nu-bromazepam - Tab 6mg |
Nu-bromazepam - Tab 3mg |
Nu-bromazepam - Tab 1.5mg |
Normoc |
Mylan-bromazepam |
Lexomil |
Lexilium |
Lexaurin |
Lekotam |
Lectopam Tab 6mg |
Lectopam Tab 3mg |
Lectopam Tab 1.5mg |
Gen-bromazepam - Tab 6mg |
Gen-bromazepam - Tab 3mg |
Durazanil |
Creosedin |
Calmepam |
Bromazepam-6 - Tab 6mg |
Bromazepam-3 - Tab 3mg |
Bromazepam-1.5 - Tab 1.5mg |
Apo-bromazepam - Tab 6mg |
Apo-bromazepam - Tab 3mg |
Apo-bromazepam - Tab 1.5mg |
Alti-bromazepam 6mg Tablets |
Alti-bromazepam 3mg Tablets |
Alti-bromazepam 1.5mg Tablets |
1812-30-2 |
DB01558 |
KL-001 |
5-26-05-00078 (BEILSTEIN HANDBOOK REFERENCE) |
GEN-BROMAZEPAM |
7-BROMO-5-(2-PYRIDYL)-3H-1,4-BENZODIAZEPIN-2(1H)-ONE |
LA XVII |
LECTOPAM (TN) |
COMPENDIUM |
BROMAZEPAM [USAN:INN:BAN:JAN] |
BRN 0618645 |
B4144_SIGMA |
2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-7-BROMO-5-(2-PYRIDYL)- |
BROMAZEPAMUM |
BROMAZEPAMUM [INN-LATIN] |
NU-BROMAZEPAM |
LS-34139 |
DEA NO. 2748 |
EINECS 217-322-4 |
37355-30-9 |
10476910 |
7-BROMO-5-(2-PYRIDYL)-3H-1,4-BENZODIAXEPIN-2(1H)-ONE |
APO-BROMAZEPAM |
DAP001035 |
KL 001 |
NOVO-BROMAZEPAM |
RO 53350 |
SOMALIUM |
2H-1,4-BENZODIAZEPIN-2-ONE, 7-BROMO-1,3-DIHYDRO-5-(2-PYRIDINYL)- |
1,3-DIHYDRO-7-BROMO-5-(2-PYRIDYL)-2H-1,4-BENZODIAZEPIN-2-ONE |
PASCA;OI, |
2H-1,4-BENZODIAZEPIN-2-ONE, 7-BROMO-1,3-DIHYDRO-5-(2-PYRIDYL)- |
2441 |
D01245 |
NSC 140669 |
BROMAZEPAM(USAN |
RO 4-9253 |
RO 5-3350 |
COMPEDIUM |
7-BROMO-1,3-DIHYDRO-5-(2-PYRIDYL)-2H-1,4-BENZDIAZEPIN-2-ONE |
WLN: T67 GMV JN IHJ CE K- BT6NJ |
NSC140669 |
BROMAZEPAMUM [LATIN] |
MOLPORT-003-940-453 |
LEXOTANIL |
B4144_FLUKA |
ZINC00001051 |
CID2441 |
7-BROMO-5-PYRIDIN-2-YL-1,3-DIHYDRO-1,4-BENZODIAZEPIN-2-ONE |
7-BROMO-1,3-DIHYDRO-5-(2-PYRIDYL)-2H-1,4-BENZODIAZEPIN-2-ONE |
AC1L1DON |
BROMAZEPAM (JP15/USAN/INN) |
NCHEMBIO747-COMP38 |
C14H10BRN3O |
7-BROMO-5-(2-PYRIDINYL)-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE # |
7-BROMO-5-(PYRIDIN-2-YL)-2,3-DIHYDRO-1H-1,4-BENZODIAZEPIN-2-ONE |
7-BROMO-5-(PYRIDIN-2-YL)-1H-BENZO[E][1,4]DIAZEPIN-2(3H)-ONE |
7-BROMO-1,3-DIHYDRO-5-(2-PYRIDYL)--2H-1,4-BENZODIAZEPIN-2-ONE |
7-BROMO-1,3-DIHYDRO-5-(2-PYRIDINYL)-2H-1,4-BENZODIAZEPIN-2-ONE |
7-BROMO-5-(2-PYRIDYL)-1,3-DIHYDRO-1,4-BENZODIAZEPIN-2-ONE |
3B3-045950 |
2H-1, 7-BROMO-1,3-DIHYDRO-5-(2-PYRIDINYL)- |
2H-1, 7-BROMO-1,3-DIHYDRO-5-(2-PYRIDYL)- |
FT-0663609 |
FT-0663608 |
ZB000229 |
SMR000058724 |
HE319728 |
HE016143 |
AN-22177 |
NSC-140669 |
7-BROMO-1,4-BENZODIAZEPIN-2-ONE |
X015L14V0O |
CTK7H4369 |
BROMAZEPAM (JP16/USAN/INN) |
ZINC1051 |
MLS003899212 |
SCHEMBL43933 |
LEXOMIL|||LEXOTANIL |
LEXOTAN, LEXOTANIL |
BROMAZEPAM-D4 |
VMIYHDSEFNYJSL-UHFFFAOYSA-N |
UNII-X015L14V0O |
Drug Categories | tranquilizing agents |
Drug Categories | therapeutic uses |
Drug Categories | psychotropic drugs |
Drug Categories | psycholeptics |
Drug Categories | physiological effects of drugs |
Drug Categories | pharmacologic actions |
Drug Categories | neurotransmitter agents |
Drug Categories | nervous system |
Drug Categories | molecular mechanisms of pharmacological action |
Drug Categories | heterocyclic compounds, 2-ring |
Drug Categories | heterocyclic compounds |
Drug Categories | gaba modulators |
Drug Categories | gaba agents |
Drug Categories | cytochrome p-450 cyp3a4 substrates |
Drug Categories | cytochrome p-450 cyp2e1 inhibitors |
Drug Categories | cytochrome p-450 cyp2c19 substrates |
Drug Categories | cytochrome p-450 cyp1a2 substrates |
Drug Categories | chemical actions and uses |
Drug Categories | central nervous system depressants |
Drug Categories | central nervous system agents |
Drug Categories | benzodiazepinones |
Drug Categories | benzodiazepines |
Drug Categories | benzodiazepine derivatives |
Drug Categories | benzazepines |
Drug Categories | anti-anxiety agents |
Drug Groups | illicit |
Drug Groups | approved |
Drug Type | small molecule |
FDA Approval | Approved before 1982 |
Drug Class | small molecule |
Drug Indications | Hypnotics and Sedatives |
Drug Class | hypnotics and sedatives |
Year of Approval | approved before 1982 |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
Lectopam Tab 6mg | Drug Brand |
BROMAZEPAM | DrugBank Drug Name |
Lectopam | Drug Synonym |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | illicit |
BROMAZEPAM | Primary Drug Name |
Year of Approval | approved before 1982 |
Drug Class | hypnotics and sedatives |
Drug Indications | Hypnotics and Sedatives |
Drug Class | small molecule |
FDA Approval | Approved before 1982 |
C14H10BRN3O | Drug Synonym |
NCHEMBIO747-COMP38 | Drug Synonym |
LECTOPAM | Drug Synonym |
BROMAZEPAM | pubchem_primary_name |
2441 | PubChem CID |
COMPEDIUM | Drug Synonym |